IP Library Patent Application 17497422
Patent Application
App. No. 17/497,422

OXYGEN-INSENSITIVE ELECTROCHEMICAL BIOSENSOR AND METHODS OF USE THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/497,422
Abstract

The present disclosure provides a reagent for detecting an analyte, comprising: an enzyme comprising glucose oxidoreductase; at least one electroactive molecule selected from resazurin, resazurin salt, resorufin or resorufin salt; and at least one metal coordination complex.

Claims (37)

1 . A reagent for detecting an analyte, comprising:

an enzyme comprising glucose oxidoreductase;

at least one electroactive molecule selected from resazurin, resazurin salt, resorufin or resorufin salt; and

at least one metal coordination complex.

2 . The reagent according to claim 1 , wherein the glucose oxidoreductase is glucose dehydrogenase.

3 . The reagent according to claim 1 , wherein the at least one metal coordination complex comprises a ruthenium complex or an osmium complex.

4 . The reagent according to claim 1 , wherein the at least one electroactive molecule is provided in concentration of between 0.01 mM and about 20 mM.

5 . The reagent according to claim 1 , wherein the at least one electroactive molecule comprises resazurin or resazurin salt is provided in concentration of between 1 mM and about 3 mM.

6 . The reagent according to claim 1 , wherein the at least one electroactive molecule comprises resorufin or resorufin salt is provided in concentration of between 1 mM and about 4 mM.

7 . The reagent according to claim 1 , further comprising a coenzyme comprising flavin adenine dinucleotide or nicotinamide adenine dinucleotide.

8 . A test strip for detecting an analyte, comprising:

a substrate with a proximal region and a distal region;

a conductive pattern formed on the substrate including at least one electrode disposed on the substrate at the proximal region of the substrate, electrical strip contacts disposed on the substrate at a conductive region at the distal region of the substrate, and conductive traces electrically connecting the at least one electrode to at least some of the electrical strip contacts; and

a reagent layer contacting at least a portion of at least one electrode, the reagent layer comprising:

a glucose oxidoreductase;

a mediator formulation comprising at least one electroactive molecule independently selected from resazurin, resazurin salt, resorufin or resorufin salt; and

at least one metal coordination complex.

9 . The test strip according to claim 8 , wherein the glucose oxidoreductase is glucose dehydrogenase.

10 . The test strip according to claim 8 , wherein the at least one metal coordination complex comprises a ruthenium complex or an osmium complex.

11 . The test strip according to claim 8 , wherein the at least one electroactive molecule is provided in concentration of between 0.01 mM and about 20 mM.

12 . The test strip according to claim 8 , wherein the at least one electroactive molecule comprises resazurin or resazurin salt is provided in concentration of between 1 mM and about 3 mM.

13 . The test strip according to claim 8 , wherein the at least one electroactive molecule comprises resorufin or resorufin salt is provided in concentration of between 1 mM and about 4 mM.

14 . The test strip according to claim 8 , further comprising a coenzyme comprising flavin adenine dinucleotide or nicotinamide adenine dinucleotide.

15 . A system for measuring a body fluid constituent comprising:

a test strip for detecting an analyte comprising:

a substrate with a proximal region and a distal region;

a conductive pattern formed on the substrate including at least one electrode disposed on the substrate at the proximal region of the substrate, electrical strip contacts disposed on the substrate at a conductive region at the distal region of the substrate, and conductive traces electrically connecting the at least one electrode to at least some of the electrical strip contacts; and

a reagent layer contacting at least a portion of at least one electrode, the reagent layer comprising:

a glucose oxidoreductase;

a mediator formulation comprising at least one electroactive molecule independently selected from resazurin, resazurin salt, resorufin or resorufin salt; and

at least one metal coordination complex; and

a diagnostic meter configured to receive the test strip and to electrically connect to the electrical strip contacts.

16 . The system according to claim 15 , wherein the glucose oxidoreductase is glucose dehydrogenase.

17 . The system according to claim 15 , wherein the at least one metal coordination complex comprises a ruthenium complex or an osmium complex.

18 . The system according to claim 15 , wherein the at least one electroactive molecule is provided in concentration of between 0.01 mM and about 20 mM.

19 . The system according to claim 15 , wherein the at least one electroactive molecule comprises resazurin or resazurin salt is provided in concentration of between 1 mM and about 3 mM.

20 . The system according to claim 15 , wherein the at least one electroactive molecule comprises resorufin or resorufin salt is provided in concentration of between 1 mM and about 4 mM.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Aug 29, 2025
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: TRIVIDIA HEALTH, INC.; TRIVIDIA HEALTHCARE SYSTEMS, LLC
Reel/Frame 072750/0552 →
SECURITY INTEREST Recorded Jan 30, 2023
From: TRIVIDIA HEALTH, INC.
To: WELLS FARGO BANNK, NATIONAL ASSSOCIATIUON
Reel/Frame 062536/0823 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2021
From: BUI, NGOC MINH PHUONG; LACKORE, JANETTE; GENDRON, JESSICA; IVEY, AARON
To: TRIVIDIA HEALTH, INC.
Reel/Frame 058046/0415 →